Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case

Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study

Published:2022-10 Issue: Volume:Volume 14 Page:1217-1227
ISSN:1179-1349
Container-title:Clinical Epidemiology
language:en
Short-container-title:CLEP

Author:

Koponen Marjaana,Paakinaho Anne,Lin Julian^ORCID,Hartikainen Sirpa,Tolppanen Anna-Maija^ORCID

Publisher

Informa UK Limited

Subject

Epidemiology

Reference44 articles.

1. Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations

2. Emerging therapies in Parkinson disease — repurposed drugs and new approaches

3. Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery

4. Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology

5. The epidemiology of Parkinson's disease: risk factors and prevention

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders;Clinical Epidemiology;2023-12

2. Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease;Neurology;2023-11-21

3. Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries;PLOS ONE;2023-05-17

4. A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson’s disease;Frontiers in Pharmacology;2023-01-19

5. Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics;Frontiers in Neuroscience;2023-01-09